Xconomy National

Archives

by in

Entry	Author	Date	Location
Alnylam Cuts One-Third of Workforce, To Save Cash for RNAi Clinical Plans	Luke Timmerman	01/19/12	Boston
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug	Luke Timmerman	01/04/12	Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers	Erin Kutz	12/16/11	Boston
Alnylam Racing to Prove RNAi Works, For a Disease You’ve Never Heard Of	Luke Timmerman	12/13/11	Boston
Marina Biotech Finds $15M From Investor to Keep Pursuing RNAi Drugs	Luke Timmerman	10/17/11	Seattle
Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News	Erin Kutz	10/07/11	Boston
Tweetchat on RNA Interference Upstages iPhone (Not Really, but It Was Still Fun)	Luke Timmerman	10/05/11	National
Marina Biotech Ends Bothell Lease on Nasal Spray Building, Coughs up Shares to Landlord	Luke Timmerman	10/04/11	Seattle
Join Us at 1 pm Eastern/10 am Pacific for RNAi “Tweetchat” with Alnylam’s John Maraganore	Luke Timmerman	10/04/11	National
RXi Splits Up, Zeo Launches Mobile Sleep-Tracking App, Karuna Licenses Schizophrenia Compounds, & More Boston-Area Life Sciences News	Erin Kutz	09/30/11	Boston
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News	Luke Timmerman	09/29/11	Seattle
Join Us for a Live ‘Tweetchat’ on the Future of RNAi, With Guest John Maraganore of Alnylam	Luke Timmerman	09/28/11	National
Marina Biotech Shuffles Management Team, as RNAi Falls Out of Favor, Cash Runs Low	Luke Timmerman	09/07/11	Seattle
AVI Starts Duchenne Trial	Luke Timmerman	08/15/11	Seattle
Time to Cure Cancer or Stash Cash Under the Mattress?	Luke Timmerman	08/15/11	National
Adventrx Shares Plummet, Pfizer Adds UC San Diego to its Network, New RNAi Center Opens, & More San Diego Life Sciences News	Bruce V. Bigelow	08/11/11	San Diego
Merck Shuts Down RNAi Research Center in SF, Cutting 50 Jobs	Luke Timmerman	07/29/11	San Francisco
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News	Erin Kutz	07/29/11	Boston
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company	Luke Timmerman	06/02/11	Seattle
Marina Biotech Adds $6.9M	Luke Timmerman	05/17/11	Seattle
Will Biotech Ever Again Captivate the Public Imagination, Like Facebook or LinkedIn?	Luke Timmerman	05/16/11	National
Alnylam Responds to Tekmira Suit	Luke Timmerman	04/06/11	Boston
AVI Biopharma Adds $30M	Luke Timmerman	04/01/11	Seattle
RXi Buys Apthera, Names New CEO	Luke Timmerman	03/31/11	Boston
AVI Biopharma Adds Chief Scientist	Luke Timmerman	03/28/11	Seattle
Who’s Going to Pay for Future Drug Development? (Part 1)	Stewart Lyman	03/22/11	National
Alnylam CEO: Tekmira Accusation of Trade Secret Misuse was a “Big Surprise”	Luke Timmerman	03/18/11	Boston
Tekmira Sues Alnylam, Alan Aderem Bolts to Seattle BioMed, Dendreon’s Warhorse Retires, & More Seattle-Area Life Sciences News	Luke Timmerman	03/17/11	Seattle
Tekmira Sues Alnylam for $1 Billion, Accusing Partner of Misusing RNAi Trade Secrets	Luke Timmerman	03/16/11	Boston
PhaseRx Angles for a Deal, Tom Clement’s New Device Gig(s), InDi’s Alzheimer’s Plan, & More in the Life Science Innovation Northwest Wrap-Up	Luke Timmerman	03/04/11	Seattle
Page 1 of 6	next page »